| 81 |
Treatment for anal fissure: Is there a safe option? |
2017 |
| 82 |
Treatment for anal fissure: Is there a safe option? |
2017 |
| 83 |
Using Modified Frailty Index to Predict Safe
Discharge Within 48 Hours of Ileostomy Closure |
2017 |
| 84 |
Using Modified Frailty Index to Predict Safe
Discharge Within 48 Hours of Ileostomy Closure |
2017 |
| 85 |
Using Modified Frailty Index to Predict Safe
Discharge Within 48 Hours of Ileostomy Closure |
2017 |
| 86 |
Using Modified Frailty Index to Predict Safe
Discharge Within 48 Hours of Ileostomy Closure |
2017 |
| 87 |
Adjuvant intravesical instillation for primary intermediate and high-risk non-muscle invasive bladder cancer: BCG versus docetaxel.
|
2016 |
| 88 |
Alvimopan in the setting of colorectal resection with an ostomy: To use or not to use? |
2016 |
| 89 |
Alvimopan in the setting of colorectal resection with an ostomy: To use or not to use? |
2016 |
| 90 |
Anterior Versus Conventional Approach for Resection
of Large Right Lobe Hepatocellular Carcinoma |
2016 |
